Intermolecular Stock Today

Equity ratings for Intermolecular are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of December 2022 and ending today, the 27th of January 2023. Click here to learn more.
Intermolecular cannot be verified against its exchange. It appears that Intermolecular is not available for investing at the moment. Please verify the symbol is currently traded on NMS Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Intermolecular Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Intermolecular's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Intermolecular or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
President CEOChristian Kramer
Average Analyst Recommendation
Analysts covering Intermolecular report their recommendations after researching Intermolecular's financial statements, talking to executives and customers, or listening in on Intermolecular's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Intermolecular. The Intermolecular consensus assessment is calculated by taking the average forecast from all of the analysts covering Intermolecular.
Strong Buy1 Opinion
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Intermolecular based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Intermolecular financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares Diluted39.8 M44.7 M
Fairly Down
Up
Slightly volatile
Weighted Average Shares39.8 M44.7 M
Fairly Down
Up
Slightly volatile
Net Cash Flow from Operations5.8 M5.3 M
Significantly Up
Up
Slightly volatile
Current Liabilities7.5 M7.3 M
Fairly Up
Down
Slightly volatile
Total Liabilities10.6 M10.4 M
Fairly Up
Down
Slightly volatile
Gross Margin57.7563.24
Significantly Down
Up
Slightly volatile
Total Debt21.6 M20.7 M
Sufficiently Up
Down
Slightly volatile
Asset Turnover0.630.69
Significantly Down
Up
Slightly volatile
Current Assets53.6 M39.9 M
Significantly Up
Down
Slightly volatile
Total Assets74.4 M49.9 M
Way Up
Down
Slightly volatile
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Intermolecular's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
Financial Strength
Intermolecular's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Intermolecular's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Intermolecular's financial leverage. It provides some insight into what part of Intermolecular's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Intermolecular's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Intermolecular deploys its capital and how much of that capital is borrowed.
Liquidity
Intermolecular cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 13.65 M in debt with debt to equity (D/E) ratio of 49.1, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Intermolecular has a current ratio of 4.65, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Intermolecular until it has trouble settling it off, either with new capital or with free cash flow. So, Intermolecular's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intermolecular sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intermolecular to invest in growth at high rates of return. When we think about Intermolecular's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

5.77 Million
Intermolecular (IMI) is traded on NMS Exchange in USA and employs 88 people. The company currently falls under 'Micro-Cap' category with a total capitalization of 59.71 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Intermolecular's market, we take the total number of its shares issued and multiply it by Intermolecular's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Intermolecular runs under Technology sector within Semiconductor Equipment & Materials industry. The entity has 49.76 M outstanding shares of which 4.43 K shares are currently shorted by investors with about 0.03 days to cover. Intermolecular has about 23.91 M in cash with (6.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48.
Check Intermolecular Probability Of Bankruptcy

Intermolecular Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Intermolecular that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Intermolecular's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Intermolecular's value.
InstituionSecurity TypeTotal SharesValue
Wolverine Asset Management LlcCommon Shares14.4 K71 K
Wells Fargo CompanyCommon Shares1.4 KK
View Intermolecular Diagnostics

Intermolecular Stock Against Markets

Picking the right benchmark for Intermolecular stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Intermolecular stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Intermolecular is critical whether you are bullish or bearish towards Intermolecular at a given time.
Intermolecular cannot be verified against its exchange. It appears that Intermolecular is not available for investing at the moment. Please verify the symbol is currently traded on NMS Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

Intermolecular Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intermolecular stock to make a market-neutral strategy. Peer analysis of Intermolecular could also be used in its relative valuation, which is a method of valuing Intermolecular by comparing valuation metrics with similar companies.
ASML Holding NVApplied MaterialsLam Research CorpKLA-TencorASM InternationalTexas Capital BancsharesAmerican AirlinesAlcoa CorpApple IncBest BuyCitigroupSentinelOneCVS Health CorpChevron CorpHome Depot
 Risk & Return  Correlation

Intermolecular Corporate Directors

Intermolecular corporate directors refer to members of an Intermolecular board of directors. The board of directors generally takes responsibility for the Intermolecular's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Intermolecular's board members must vote for the resolution. The Intermolecular board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Thomas Baruch - Independent DirectorProfile
Kenneth Traub - Independent DirectorProfile
Jonathan Schultz - DirectorProfile
Matthew Furnas - DirectorProfile

Invested in Intermolecular?

The danger of trading Intermolecular is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Intermolecular is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Intermolecular. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Intermolecular is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Tools for Intermolecular Stock

When running Intermolecular price analysis, check to measure Intermolecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intermolecular is operating at the current time. Most of Intermolecular's value examination focuses on studying past and present price action to predict the probability of Intermolecular's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Intermolecular's price. Additionally, you may evaluate how the addition of Intermolecular to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators